Contact
Let’s get in contact

eviSIMILAR

Support your assay development and preclinical characterization with reliable antibody analogs. Available in 1 mg, 5 mg, and 50 mg quantities.

  • anti-TNFα (adalimumab)

    anti-TNFα (adalimumab)

    Human IgG1. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-CD52 (alemtuzumab)

    anti-CD52 (alemtuzumab)

    Humanized IgG. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-EGFR (panitumumab)

    anti-EGFR (panitumumab)

    Human IgG2. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • murine anti-CD3 (muromonab)

    murine anti-CD3 (muromonab)

    Murine IgG2a. 5 mg/mL.

    225,00 CHF

  • anti-Complement C5 (eculizumab)

    anti-Complement C5 (eculizumab)

    Humanized IgG2/4 hybrid. H264Q, F296Y, V305L, A326S, P327S, T335A, R351Q, M393V, K405R, Q415E, P441L. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-IgE (omalizumab)

    anti-IgE (omalizumab)

    Humanized IgG1. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-EGFR (cetuximab)

    anti-EGFR (cetuximab)

    Chimeric (mouse–human) IgG1. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-CTLA-4 (ipilimumab)

    anti-CTLA-4 (ipilimumab)

    Human IgG1. K214R. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-HER2 domain II (pertuzumab)

    anti-HER2 domain II (pertuzumab)

    Humanized IgG1. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-CD20 (rituximab)

    anti-CD20 (rituximab)

    Chimeric (mouse–human) IgG1. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-HER2 domain IV (trastuzumab)

    anti-HER2 domain IV (trastuzumab)

    Humanized IgG1. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).

    225,00 CHF

  • anti-VEGF (bevacizumab)

    anti-VEGF (bevacizumab)

    Humanized IgG1. 5 mg/mL in 30mM phosphate pH 5.5.

    225,00 CHF

Place your order

Send us your order, and we will contact you promptly with delivery and payment details.

Total

Taken from your quote list.